Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...

Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed.

Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of ...

A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...